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Résumé en
anglais
To assess the effect of colistin-glycopeptide combination against a multidrug-
resistant strain of .  We used procedures (Etest method, checkerboard test and kill-
time assays) and a mouse model of a carbapenem-resistant pneumonia. The colistin-
teicoplanin combination allowed a 74% increase of the survival in the mouse model
within the 4 days following bacterial inoculation as compared with saline or colistin
alone (p = 0.06). Concurrently, the colistin-vancomycin combination presented a
similar efficacy as compared with saline or colistin alone in the mouse model.
According to those preliminary results, using the colistin-teicoplanin combination in
therapeutic deadlocks encountered in certain multiresistant pneumonia could be
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